First COPD biomarker approved by FDA

The FDA has approved the first COPD biomarker for use in interventional clinical trials. The blood biomarker plasma fibrinogen can now be used in studies that examine exacerbations and/or all-cause mortality in patients with COPD, the regulatory body said in a statement. The initial biomarkers selected were plasma fibrinogen, St. George’s Respiratory Questionnaire, and the 6-minute walk test. ...

Already a member?

Login to keep reading.

© 2021 the limbic